Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate in Children With Osteogenesis Imperfecta
NCT00005901Phase 3Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jun 2000
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of pamidronate in osteogenesis imperfecta (OI), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Jun 2000; status: completed.
02
Drugs
pamidronate
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on NCT00005901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005901.